Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural.
Research led by Weill Cornell Medicine provides new evidence that most colorectal cancers begin with the loss of intestinal stem cells, even before cancer-causing genetic alterations appear.
Tim Barry ’93 co-founded a health care company that offers primary care, multispecialty and urgent care options to 1.6 million patients throughout the U.S.
Denise Rose worked with other Cornell students on a study of mental health in India through the Cornell-Keystone Nilgiris Field Learning Summer Program.
Researchers comparing intestinal samples of children with Crohn’s disease and healthy children found one molecule that shows significant differences between the two groups.
Professor Sean Nicholson, director of the Cornell Sloan Program in Health Administration, explores the future of biopharma with industry experts in the Keynote webcast “Bringing New Science to Market.”
By discovering how a type of smooth muscle forms in the gut, scientists have opened doors to making artificial muscle, repairing muscle following gut surgeries and treating inflammatory bowel disease and obesity.
Blocking the formation of filaments – multi-enzyme structures that fuel cancer activity – may offer new ways to control cancer cell proliferation, according to a new study led by Cornell researchers.